BCG With or Without Mitomycin in Treating Patients With Bladder Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Biological therapies such as BCG use different ways to stimulate the immune system
and stop tumor cells from growing. Drugs used in chemotherapy use different ways to stop
tumor cells from dividing so they stop growing or die. Combining chemotherapy with biological
therapy may kill more tumor cells. It is not yet known if BCG is more effective with or
without mitomycin.
PURPOSE: Randomized phase II trial to compare the effectiveness of BCG plus mitomycin with
that of BCG alone in treating patients who have bladder cancer.
Phase:
Phase 2
Details
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC